Bischopberger rules out adding GS-5885, which has weak activity against genotype-3.
Since GILD is currently testing Sofo/5885 in GT3 it hasn't been ruled out but it's true expectations are low. The GT3 results from Sofo/Riba have set a low bar so it should be an interesting comparison.